Yamaguchi Grand Medical Center Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2003
NCT00135551
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Seiji Umemoto, M.D., Ph.D. | Yamaguchi Clinic